adient plc - ADNT
ADNT
Close Chg Chg %
19.30 0.05 0.23%
Closed Market
19.35
+0.05 (0.23%)
Volume: 257.66K
Last Updated:
Dec 24, 2025, 12:59 PM EDT
Company Overview: adient plc - ADNT
ADNT Key Data
| Open $19.36 | Day Range 19.25 - 19.60 |
| 52 Week Range 10.04 - 26.16 | Market Cap $1.53B |
| Shares Outstanding 79.15M | Public Float 77.54M |
| Beta 1.63 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$3.33 |
| Yield 0.00% | Dividend $0.28 |
| EX-DIVIDEND DATE Oct 23, 2018 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.15M |
ADNT Performance
| 1 Week | -1.07% | ||
| 1 Month | -0.46% | ||
| 3 Months | -21.39% | ||
| 1 Year | 11.07% | ||
| 5 Years | -43.98% |
ADNT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
13
Full Ratings ➔
About adient plc - ADNT
Adient plc designs, manufactures, and markets automotive seating systems. It operates through the following geographical segments: Americas, EMEA, and Asia. The company was founded in 1985 and is headquartered in Plymouth, MI.
ADNT At a Glance
Adient plc
49200 Halyard Drive
Plymouth, Michigan 48170
| Phone | 1-734-254-5000 | Revenue | 14.54B | |
| Industry | Auto Parts: OEM | Net Income | -281,000,000.00 | |
| Sector | Producer Manufacturing | Employees | 65,000 | |
| Fiscal Year-end | 09 / 2026 | |||
| View SEC Filings |
ADNT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.138 |
| Price to Book Ratio | 1.079 |
| Price to Cash Flow Ratio | 4.45 |
| Enterprise Value to EBITDA | 5.281 |
| Enterprise Value to Sales | 0.281 |
| Total Debt to Enterprise Value | 0.65 |
ADNT Efficiency
| Revenue/Employee | 223,615.385 |
| Income Per Employee | -4,323.077 |
| Receivables Turnover | 7.76 |
| Total Asset Turnover | 1.588 |
ADNT Liquidity
| Current Ratio | 1.121 |
| Quick Ratio | 0.932 |
| Cash Ratio | 0.26 |
ADNT Profitability
| Gross Margin | 6.839 |
| Operating Margin | 3.089 |
| Pretax Margin | -0.605 |
| Net Margin | -1.933 |
| Return on Assets | -3.07 |
| Return on Equity | -14.41 |
| Return on Total Capital | -6.356 |
| Return on Invested Capital | -6.226 |
ADNT Capital Structure
| Total Debt to Total Equity | 150.34 |
| Total Debt to Total Capital | 60.054 |
| Total Debt to Total Assets | 29.652 |
| Long-Term Debt to Equity | 145.074 |
| Long-Term Debt to Total Capital | 57.951 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Adient Plc - ADNT
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 14.12B | 15.39B | 14.69B | 14.54B | |
Sales Growth
| +3.22% | +9.02% | -4.59% | -1.04% | |
Cost of Goods Sold (COGS) incl D&A
| 13.32B | 14.42B | 13.72B | 13.54B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 350.00M | 340.00M | 332.00M | 325.00M | |
Depreciation
| 298.00M | 290.00M | 285.00M | 279.00M | |
Amortization of Intangibles
| 52.00M | 50.00M | 47.00M | 46.00M | |
COGS Growth
| +3.64% | +8.26% | -4.84% | -1.32% | |
Gross Income
| 801.00M | 975.00M | 966.00M | 994.00M | |
Gross Income Growth
| -3.26% | +21.72% | -0.92% | +2.90% | |
Gross Profit Margin
| +5.67% | +6.33% | +6.58% | +6.84% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 589.00M | 549.00M | 507.00M | 545.00M | |
Research & Development
| 322.00M | 362.00M | 372.00M | 387.00M | |
Other SG&A
| 267.00M | 187.00M | 135.00M | 158.00M | |
SGA Growth
| +13.71% | -6.79% | -7.65% | +7.50% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 67.00M | 63.00M | 138.00M | 411.00M | |
EBIT after Unusual Expense
| 145.00M | 363.00M | 321.00M | 38.00M | |
Non Operating Income/Expense
| 97.00M | 135.00M | 44.00M | 79.00M | |
Non-Operating Interest Income
| 9.00M | 22.00M | 28.00M | 24.00M | |
Equity in Earnings of Affiliates
| 75.00M | 84.00M | 90.00M | 69.00M | |
Interest Expense
| 188.00M | 203.00M | 232.00M | 205.00M | |
Interest Expense Growth
| -27.13% | +7.98% | +14.29% | -11.64% | |
Gross Interest Expense
| 188.00M | 203.00M | 232.00M | 205.00M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 54.00M | 295.00M | 133.00M | (88.00M) | |
Pretax Income Growth
| -96.25% | +446.30% | -54.92% | -166.17% | |
Pretax Margin
| +0.38% | +1.92% | +0.91% | -0.61% | |
Income Tax
| - | 94.00M | 32.00M | 103.00M | |
Income Tax - Current - Domestic
| 6.00M | 4.00M | 5.00M | 14.00M | |
Income Tax - Current - Foreign
| 83.00M | 120.00M | 28.00M | 117.00M | |
Income Tax - Deferred - Domestic
| - | - | (1.00M) | 1.00M | - |
Income Tax - Deferred - Foreign
| 6.00M | (125.00M) | (1.00M) | (28.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 75.00M | 84.00M | 90.00M | 69.00M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (40.00M) | 295.00M | 101.00M | (191.00M) | |
Minority Interest Expense
| 80.00M | 90.00M | 83.00M | 90.00M | |
Net Income
| (120.00M) | 205.00M | 18.00M | (281.00M) | |
Net Income Growth
| -110.83% | +270.83% | -91.22% | -1,661.11% | |
Net Margin Growth
| -0.85% | +1.33% | +0.12% | -1.93% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (120.00M) | 205.00M | 18.00M | (281.00M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (120.00M) | 205.00M | 18.00M | (281.00M) | |
EPS (Basic)
| -1.2658 | 2.1693 | 0.2011 | -3.3855 | |
EPS (Basic) Growth
| -110.76% | +271.38% | -90.73% | -1,783.49% | |
Basic Shares Outstanding
| 94.80M | 94.50M | 89.50M | 83.00M | |
EPS (Diluted)
| -1.2658 | 2.1488 | 0.1998 | -3.3855 | |
EPS (Diluted) Growth
| -110.93% | +269.76% | -90.70% | -1,794.44% | |
Diluted Shares Outstanding
| 94.80M | 95.40M | 90.10M | 83.00M | |
EBITDA
| 562.00M | 766.00M | 791.00M | 774.00M | |
EBITDA Growth
| -12.19% | +36.30% | +3.26% | -2.15% | |
EBITDA Margin
| +3.98% | +4.98% | +5.39% | +5.33% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 23.227 | |
| Number of Ratings | 13 | Current Quarters Estimate | 0.193 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 1.92 | |
| Last Quarter’s Earnings | 0.52 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.93 | Next Fiscal Year Estimate | 2.997 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 11 | 11 | 11 |
| Mean Estimate | 0.19 | 0.58 | 1.92 | 3.00 |
| High Estimates | 0.45 | 0.70 | 2.41 | 3.81 |
| Low Estimate | 0.09 | 0.43 | 1.59 | 2.18 |
| Coefficient of Variance | 53.62 | 12.74 | 12.19 | 17.52 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 9 | 8 | 8 |
| UNDERWEIGHT | 0 | 1 | 2 |
| SELL | 0 | 0 | 1 |
| MEAN | Overweight | Overweight | Hold |
SEC Filings for Adient Plc - ADNT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Adient Plc - ADNT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 14, 2025 | Frederick Arthur Henderson Director | 92,185 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Richard A. A. Goodman Director | 50,777 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Barbara Jean Samardzich Director | 50,388 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Peter Harold Carlin Director | 38,470 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | José M. Gutiérrez Director | 47,141 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Julie L. Bushman Director | 51,458 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Jodi Eddy Director | 16,343 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 6, 2025 | Jerome Dorlack President and CEO; Director | 461,945 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 6, 2025 | Jerome Dorlack President and CEO; Director | 459,287 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.23 per share | 7,913,515.01 |